Applications under development

Oncograde : DendrisCHIP BC breast cancer recurrence prognosis

Breast cancer prognosis using original set of biomarkers and data analysis software based on fuzzy logic method. In oncology one of greatest subjects of study is how to better identify low risk recurrence population avoiding therefore chemotherapy and its secondary effects. From beginning of 2000’s new biomarkers have been selected by molecular methods in order to improve the tumor prognosis.Worldwide investment resources are dedicated to seek new efficient biomarkers able to better appreciate the risk of recurrence prognosis. Dendris is strongly involved in this research with clinical and scientific partners gathered in Oncograde R&D project. -See Publication-

Food Safety

DendrisKIT FD is dedicated to quality control in food industry. This chip identify the presence of pathogenic bacteria in food production chains. Targets are :

Bacillus cereus, Escherichia coli, Shigella spp, Listeria monocytogenes, Staphylococcus spp, Salmonella enterica, Yersinia enterocolitica